Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
October 26, 2026 by thr101.org
Hawaii Youth Vaping Plunges as More Adults Vape Than Smoke
Youth vaping in Hawaii declined by 66% between 2019 and 2025, while cigarette smoking among high school students reached its lowest recorded level. Meanwhile, more adults now report vaping than smoking, according to newly released survey data.
Despite these trends, Hawaii is introducing further restrictions on vaping products, including tighter authorisation requirements and limits on disposable devices.
The findings highlight the importance of balancing youth protection with adult access to lower-risk alternatives, particularly as policymakers consider the potential effects of additional restrictions on smoking cessation and tobacco harm reduction.
October 26, 2026 by substack.com
Mice studies to simulate children exposure to “third hand” vaping are toxicological fiction
Animal studies investigating children's exposure to residual vaping aerosol have come under scrutiny for using experimental conditions that may not reflect real-world exposure.
Researcher Roberto Sussman questions the relevance of mouse studies that expose animals to heavily contaminated materials, highlighting the lack of evidence for comparable exposure levels in everyday environments where children live.
The analysis reinforces the importance of realistic exposure assessment and scientifically valid comparisons between vaping and smoking. Reliable tobacco harm reduction research must distinguish laboratory findings from risks demonstrated under real-world conditions.
October 26, 2026 by springer.com
Changes in human biomarkers of exposure after complete switching from cigarettes to e-cigarettes or exclusive e-cigarette use: a systematic review and biomarker-specific meta-analysis
A new systematic review and meta-analysis published in Archives of Toxicology, covering 60 studies, found substantial reductions in exposure to harmful chemicals among smokers who switched completely to e-cigarettes.
Reductions ranged from approximately 61% to 92% across several biomarkers associated with tobacco smoke, while dual users experienced smaller and less consistent benefits.
Although lower toxicant exposure does not automatically establish long-term health outcomes, the findings strengthen the scientific evidence supporting complete switching as a tobacco harm reduction strategy.
October 23, 2026 by substack.com
Nicotine Dose Is Not a Proxy for Risk, But We Keep Hearing That It Is
Two recently published scientific papers have raised concerns about how nicotine dependence and smoking-related health risks are presented in medical research.
Cliff Douglas highlights a recurring problem: nicotine concentration is often treated as an indicator of harm, despite substantial differences in toxic exposure between cigarettes and smoke-free products.
The distinction is particularly important for smoking cessation, as effective nicotine delivery can help adults replace cigarettes without continued exposure to combustion. Greater scientific precision is essential to understanding relative risk and supporting evidence-based tobacco harm reduction.
October 21, 2026 by protectingtaxpayers.org
Handed Nicotine Rules Should be Eliminated to Help Smokers Quit
Pennsylvania's new nicotine regulations under Act 57 could significantly restrict access to smoke-free alternatives, with only 159 products included on the state's approved list.
The Taxpayers Protection Alliance warns that these restrictions may limit consumer choice, affect small retailers and encourage illicit trade. With around 1.4 million adults smoking in Pennsylvania, the potential consequences for tobacco harm reduction deserve attention. Effective regulation should balance product safety and youth protection with access to lower-risk alternatives for adults seeking to quit smoking.
October 20, 2026 by tobaccoharmreduction.net
Popcorn Lung Myth: Why Health Sites Still Get It Wrong
The persistent association between vaping and “popcorn lung” highlights how incomplete scientific communication can distort perceptions of health risks.
Although diacetyl, a flavouring chemical linked to occupational lung disease, was previously detected in some e-cigarettes, no confirmed cases of popcorn lung have been attributed to vaping. The chemical has also been prohibited in regulated e-liquids in the UK and EU for years.
Continued references to this risk without appropriate context may discourage smokers from switching to lower-risk alternatives. Accurate public health messaging must distinguish between potential hazards, actual exposure and established evidence.
October 20, 2026 by tobaccoharmreduction.net
Popcorn Lung Myth: Why Health Sites Still Get It Wrong
The persistent association between vaping and “popcorn lung” highlights how incomplete scientific communication can distort perceptions of health risks.
Although diacetyl, a flavouring chemical linked to occupational lung disease, was previously detected in some e-cigarettes, no confirmed cases of popcorn lung have been attributed to vaping. The chemical has also been prohibited in regulated e-liquids in the UK and EU for years.
Continued references to this risk without appropriate context may discourage smokers from switching to lower-risk alternatives. Accurate public health messaging must distinguish between potential hazards, actual exposure and established evidence.
October 19, 2026 by substack.com
Flaws in Studies of Vaping among Former Smokers
Comparing former smokers who vape with those who no longer use nicotine may produce misleading conclusions about health risks and smoking relapse.
Behavioural scientist Arielle Selya highlights a critical methodological flaw: people who quit smoking through vaping often stopped much more recently than those who quit using other methods. Differences in smoking history and time since quitting can therefore distort research findings.
Accurate assessment of vaping's risks requires better comparison groups and careful consideration of these factors, rather than attributing poorer outcomes to vaping alone.
October 19, 2026 by regulatorwatch.com
Risk Reversal | Why Americans Now Fear Vaping More Than Smoking | RegWatch
Risk perceptions of vaping in the US have shifted significantly, with 30% of adults now believing e-cigarettes are more harmful than smoking.
Research suggests that public health campaigns and the 2019 EVALI outbreak may have contributed to this misunderstanding. These findings highlight the importance of accurate risk communication, particularly for adult smokers considering lower-risk nicotine alternatives.
October 15, 2026 by substack.com
Tobacco Risk Management: An Opportunity for Health Plans to Accelerate the Decline of Cigarette Smoking
Health insurers could play a much greater role in reducing smoking-related disease in the United States. Despite smoking cessation being among the most cost-effective medical interventions, fewer than half of smokers report receiving advice or assistance to quit.
Recent developments, including cheaper cessation medications, new clinical performance measures and growing evidence on safer nicotine alternatives, offer an opportunity to change that. Integrating tobacco harm reduction into health insurance programmes could improve patient outcomes while reducing long-term healthcare costs. The priority is not simply treating smoking-related disease, but investing in preventing it.